Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Your Article Summary
Carisbamate as adjunctive treatment of partial onset seizures in adults in two randomized, placebo-controlled trials
Epilepsia, 10/29/09
Sperling MR et al. – Carisbamate 400 mg/day was effective in patients with refractory partial–onset seizures in one of these global studies. More than 200 mg/day of carisbamate is required for efficacy. Carisbamate was well–tolerated in both studies.
Related Articles
Pathologic cardiac repolarization in pharmacoresistant epilepsy and its potential role in sudden unexpected death in epilepsy: A case–control study
Epilepsia, 10/21/09
Relevance Score: 98%
Oxcarbazepine versus carbamazepine monotherapy for partial onset seizures
Cochrane Reviews, 10/09/09
Relevance Score: 97%
Treatment of refractory complex partial seizures: role of vigabatrin
Neuropsychiatric Disease and Treatment, 10/08/09
Relevance Score: 97%
Focal clinical and electroencephalographic features in patients with juvenile myoclonic epilepsy
Acta Neurologica Scandinavica, 10/22/09
Relevance Score: 96%
Positive syndrome of schizophrenia and epilepsy
Medical Hypotheses, 10/08/09
Relevance Score: 96%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
The Statin Choice decision aid in primary care: A randomized trial
Patient Education and Counselling, 12/04/09
Prasugrel for acute coronary syndromes: Faster, more potent, but higher bleeding risk
Cleveland Clinic Journal of Medicine, 12/04/09
Q: Is an ACE inhibitor plus an ARB more effective than either drug alone?
Cleveland Clinic Journal of Medicine, 12/04/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


